Stockreport

Theravance Biopharma shares plunge 26% after drug trial failure triggers strategic review [Yahoo! Finance]

Theravance Biopharma, Inc. - Ordinary Shares  (TBPH) 
Last theravance biopharma, inc. - ordinary shares earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.theravance.com/investor-relations
PDF Theravance Biopharma shares plunge 26% after drug trial failure triggers strategic review Proactive uses images sourced from Shutterstock The company is working with [Read more]